KRW 6560.0
(-4.51%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 31.77 Billion KRW | -10.26% |
2022 | 35.4 Billion KRW | 26.9% |
2021 | 27.9 Billion KRW | 31.67% |
2020 | 21.19 Billion KRW | 8.93% |
2019 | 19.45 Billion KRW | 16.02% |
2018 | 16.76 Billion KRW | 209.9% |
2017 | 5.41 Billion KRW | -15.0% |
2016 | 6.36 Billion KRW | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 34.05 Billion KRW | 7.17% |
2024 Q2 | 38.35 Billion KRW | 12.64% |
2023 Q4 | 31.77 Billion KRW | -2.43% |
2023 FY | 31.77 Billion KRW | -10.26% |
2023 Q3 | 32.56 Billion KRW | 6.45% |
2023 Q2 | 30.59 Billion KRW | -6.08% |
2023 Q1 | 32.57 Billion KRW | -8.0% |
2022 Q2 | 32.29 Billion KRW | 9.75% |
2022 Q1 | 29.42 Billion KRW | 5.48% |
2022 Q3 | 32.73 Billion KRW | 1.36% |
2022 Q4 | 35.4 Billion KRW | 8.15% |
2021 Q4 | 27.9 Billion KRW | -5.08% |
2021 Q3 | 29.39 Billion KRW | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Osang Healthcare Co.,Ltd | 15.04 Billion KRW | -111.133% |
InBody Co.,Ltd | 29.41 Billion KRW | -7.999% |
Seegene, Inc. | 137.63 Billion KRW | 76.916% |
i-SENS, Inc. | 83.54 Billion KRW | 61.969% |
Ray Co., Ltd. | 25.37 Billion KRW | -25.224% |
Gencurix Inc. | 581.02 Million KRW | -5368.167% |
Sugentech Inc. | 7.01 Billion KRW | -352.607% |
L&C Bio Co., Ltd | 46.28 Billion KRW | 31.362% |